Send to a colleague »
JUNE 2009

BioScience Bulletin

Sponsored by New York City Economic Development Corporation

Arrow In the News
Arrow NYC Company Spotlight
Arrow Events
Arrow Lab Leasing Opportunities
NYC Bioscience Bulletin provides the latest news on the thriving bioscience cluster in New York City. Visit www.nycbiotech.com for more information and be sure to download our NYC Bioscience Year in Review.
East River Science Park
BioBAT
IN THE NEWS

NYC's Academic Institutions & NYCEDC Partner at BIO 2009

The 2009 BIO International Convention, which brought together 15,000 industry leaders, provided visibility to NYC’s bioscience industry and NYC’s Academic Medical Institutions. The New York Academic Consortium (NYAC), in partnership with NYCEDC, discussed collaborative research and licensing opportunities available at academic medical institutions in NYC. NYAC offices work together to develop and share the best practices that have made NYC one of the leading sources of pharmaceutical and biotechnology products and innovation.

NYC Recognized as North American City of the Future

fDi Magazine, a publication of the Financial Times Group, has recognized NYC as the top North American City of the Future at the 2009 Bio International Convention in Atlanta, Georgia. NYC was selected out of 400 cities from across the United States, Canada, and Mexico.

New York Named in the Top 5 Biotech Regions in 2009

FierceBiotech has recognized the NYC metro area’s commitment to commercial biotech by naming the area as one of the Top 5 Biotech Regions in 2009. The publication praised the City’s commitment to the biotech sector through its development of commercial lab space for small and mid-sized companies at East River Science Park and the Brooklyn Army Terminal and showcased the momentum of the bioscience cluster in NYC.

Know a Life Science Company Looking For Funding?

Springboard Enterprises is looking for woman-led life science, medical device, health care products and services companies to present their businesses to an audience of venture, angel and corporate investors. Applications are still being accepted. The final event takes place on October 30, 2009 at Pricewaterhouse Coopers in NYC.

Cancer Discovery by MSKCC

New research led by investigators at NYC-based Memorial Sloan-Kettering Cancer Center (MSKCC) has identified three genes that act as genetic mediators in the spread of breast cancer to the brain. The study recently published in Nature, also illuminates the mechanisms by which this spread occurs.

Networking on the Hudson

Join your colleagues at the World Yacht Marina on June 16, 2009 in the NY/NJ bio & pharma communities networking and awards event of the summer. Special pricing is available for NYC biotech companies. Visit the NYBA website to learn more.

NYC to Host Second Annual World Science Festival

The World Science Festival, held June 10 – 14, will feature signature events with participation from co-chair of the President's Council of Advisors on Science and Technology, Harold Varmus, actress and playwright Anna Deavere Smith, actor Alan Alda, musician Bobby McFerrin, and Charlie Rose. NYCEDC is a government partner for the event.

City Council Vote Leads to Empire Zone Benefits at ERSP

On Wednesday, June 10th, the New York City Council approved an initiative to extend the Chinatown/Lower East Side Empire Zone to include the East River Science Park (ERSP). An Empire Zone will allow company applicants to access New York State tax benefits and further support the growth of New York City's biotechnology industry. The initiative was created in partnership with the Chinatown/Lower East Side Empire Zone.

Back to Top^
NYC COMPANY SPOTLIGHT
Angioblast Systems
Angioblast Systems

Angioblast Systems, Inc. is a private biotech company committed to the development of novel biological treatments for cardiac and vascular disorders. Their proprietary adult stem cell technology platform enables development of allogeneic or "off-the-shelf" products which can treat tens of thousands of patients from a single universal donor. Angioblast's lead products target chronic heart failure, heart attacks, macular degeneration/diabetic retinopathy, and bone marrow transplantation, and the company is in the midst of Phase II clinical trials.

Recently, Angioblast announced interim results from their Phase II chronic heart failure trial which showed significant improvement in heart muscle function in patients receiving their proprietary allogeneic adult stem cells.

 
Back to Top^
EVENTS
June World Science Festival
New York City
10-14
June NYBA's BioCruise on the Hudson River
World Yacht Marina
16
June The New York Venture Summit
Digital Sandbox
17
June Circadian Disruption and Cancer
The New York Academy of Science
19
June New York Post NYC Start-Up
Metropolitan Pavilion
24
 
Visit the NYC Bioscience Initiative web site for a complete calendar of events.
Back to Top^
LAB LEASING OPPORTUNITIES
Bulletpoint Audubon Incubator at Columbia University Medical Center
Bulletpoint BioBAT at Brooklyn Army Terminal
Bulletpoint Commercial Synthetic Chemistry Facility at SUNY Downstate Biotechnology Park
Bulletpoint East River Science Park
Bulletpoint Incubator at SUNY Downstate Biotechnology Park
 
Back to Top^
New York City Economic Development Corporation For more information on the latest Bioscience activities in New York City and how NYCEDC can assist your business, visit us at www.nycbiotech.com or contact Lenzie Harcum at 212-312-3806. If you’d like to receive the NYC Bioscience Bulletin regularly, subscribe now. To prevent future emails from being filtered out by you spam blocker, please add nycbioscience@nycedc.com to your address book. If you no longer wish to receive the NYC Bioscience Bulletin, please unsubscribe.